The tests can still be used, CDC says, as urgency over possible outbreak grows

First Be(I) compounds to be crystallized could open up new main group chemistry

Petrochemical and pharma meeting organizers say travel was becoming too difficult; ACS spring meeting is still on

Multiple catalysts do complex chemistry to give a simple product

Purchase brings the instrumentation giant into the fight against coronavirus

Activists say contracts with companies violate federal law

Draft assessment confirms concerns about health effects of chlorinated solvent

The $4.9 billion deal adds a mid-stage cancer drug to the big biotech's pipeline

Single-crystal boron nitride could enable the use of 2-D materials for transistors in computer chips

Product launches and champagne toasts at instrumentation conference bely worries about infection

Early batches of the test can still be used, CDC says, while affirming it will deploy new kits

Congress opts for open-ended support for federal and local agencies

The structure shows the first steps of SARS-CoV-2 infection, and could help in drug discovery

Ajay Mallia of Georgia Gwinnett College is named the national winner

Petrochemical and pharma meeting organizers say travel was becoming too difficult; ACS spring meeting is still on

Gilead has a head start on an antiviral, while Moderna is pursuing a novel mRNA vaccine

Product launches and champagne toasts belied worries about infection

Colibactin causes key cancer mutations

First Be(I) compounds to be crystallized could open up new main-group chemistry

Method provides petroleum-free way to turn industrial biowaste into valuable commodity

160-million-atom simulation reveals potential drug targets

Shocked to learn how little plastic gets recycled, the duo founded a company so they could make a difference

Lucy Therapeutics founder is taking an atypical approach to finding drugs for central nervous system diseases

Her company, MicroByre, is proving that wild microbes can be engineered to produce useful chemicals

With Curie Co., the entrepreneur designs alternatives to compounds like parabens that have fallen out of favor with retailers

Barred as a woman from becoming a brewer in India, Mazumdar-Shaw instead founded biotech firm Biocon and today focuses on affordable health care

Her company, Saule Technologies, has a low-cost process to print the solar cells on a multitude of materials

The MIT chemical engineering head is charting a course into the start-up world with LayerBio

Nanotech pioneer aims to pursue grand challenges rather than just write about them

Known as Big Sister for her mentorship, Du and her newest firm, Zai Lab, are setting new standards in Asia

Nobel Prize winner wants to solve real-world problems with directed evolution

The gene-editing tool CRISPR-Cas9 rerouted Doudna's career path. What hasn't changed for the renowned scientist and serial entrepreneur? Living and breathing the science

Gilead toma ventaja gracias a un antiviral, mientras que Moderna está buscando una nueva vacuna ARNm.

Concerns over the spread of the novel coronavirus leads to decision

C&EN looks at how scientists are adapting to travel restrictions and working from home

Spring lineup of conferences and events frequented by chemists is slashed

Hear what C&EN's pharmaceutical editors have learned about how the coronavirus is affecting drug production in China and across the globe

Creating more opportunities for dialogue is just the first step

Scientists use an alkali hydroxide–based system to turn carbon dioxide into a carbon-neutral fuel

The technique, called MicroMapping, identifies potential protein interactions on and between cells

Chemical makers brace for a slowdown on the continent

Several approved and well-studied small molecules could be repurposed as treatments for COVID-19

Microbe-specific tracers could help detect infection without relying on inflammation as a surrogate